ArticleCureus2025
Comparison of Two Different Doses of Prophylactic Intravenous Magnesium Sulphate for the Prevention of Shivering in Patients Undergoing Procedures Under Spinal Anesthesia.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionShivering is a common and distressing complication of spinal anesthesia associated with increased metabolic demand, hemodynamic fluctuations, and impaired monitoring. Magnesium sulfate (MgSO MATERIALS AND
methodsA prospective observational study was conducted at a tertiary care center over one year among 88 adult patients undergoing elective procedures under spinal anesthesia. Participants were allocated into two groups: Group A (50 mg/kg IV magnesium sulfate bolus) and Group B (25 mg/kg IV magnesium sulfate bolus). Hemodynamic parameters, temperature, and shivering grades were monitored intraoperatively and postoperatively. Shivering was graded on a 0-4 scale. Data were analyzed using IBM SPSS Statistics version 20 (IBM Corp., Armonk, USA); p < 0.05 was considered statistically significant.
resultsDemographic characteristics were comparable between groups. No significant differences were observed in heart rate, systolic/diastolic blood pressure, peripheral oxygen saturation (SpO
conclusionBoth 25 mg/kg and 50 mg/kg prophylactic IV magnesium sulfate effectively prevented shivering after spinal anesthesia without significant hemodynamic instability. The lower dose (25 mg/kg) demonstrated equivalent efficacy and safety, supporting its use as a preferable dose for routine prophylaxis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.